Levonorgestrel linked to Deep Vein Thrombosis, reveals IPC Drug safety alert

Published On 2023-08-28 10:00 GMT | Update On 2023-08-28 10:00 GMT

The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of August, has revealed that Levonorgestrel, a synthetic progestogen popularly used in contraception and hormone therapy is linked with Adverse Drug Reactions (ADRs) named Deep Vein Thrombosis.

This came after a preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database.

For more details, check out the link given below:

Drug Safety Alert: Indian Pharmacopoeia Commission Reveals ADR Linked To Contraceptive Drug Levonorgestrel

Full View

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Roshni Dhar

Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Levonorgestrel linked to Deep Vein Thrombosis, reveals IPC Drug safety alert

Similar News